A 51-year-old man presented with a prodrome of arthralgia, intermittent oral ulceration, and raised inflammatory markers. He was extensively investigated; however, no firm diagnosis could be established, and he remained under regular surveillance by rheumatology and infectious disease services. After 12 months, he presented with painful ear swelling. Clinical examination revealed a swollen tender ear ( Figure 1 ) and a soft diastolic heart murmur. Serum inflammatory markers were raised, with a c-reactive protein (CRP) of 28 mg/L and an erythrocyte sedimentation rate (ESR) of 25 mm/h. Biopsy of affected cartilage showed characteristic features of auricular chondritis ( Figure 2 ). Echocardiogram (Movie I in the Data Supplement) revealed mild aortic incompetence, a left ventricular ejection fraction of 60%, aortic root dilatation, and an incidental patent foramen ovale (Movie II in the Data Supplement). Computed tomography (CT) of the thorax demonstrated no tracheal abnormality; however, aortic root dilatation of 4.6 cm was noted ( Figure 3) . A fasting positron emission tomography-CT (PET-CT) showed increased F-18 fluorodeoxyglucose accumulation in the ascending aorta ( Figure 4) , and a diagnosis of relapsing polychondritis with secondary aortitis with structural aortic dilatation was made.
A 51-year-old man presented with a prodrome of arthralgia, intermittent oral ulceration, and raised inflammatory markers. He was extensively investigated; however, no firm diagnosis could be established, and he remained under regular surveillance by rheumatology and infectious disease services. After 12 months, he presented with painful ear swelling. Clinical examination revealed a swollen tender ear ( Figure 1 ) and a soft diastolic heart murmur. Serum inflammatory markers were raised, with a c-reactive protein (CRP) of 28 mg/L and an erythrocyte sedimentation rate (ESR) of 25 mm/h. Biopsy of affected cartilage showed characteristic features of auricular chondritis ( Figure 2 ). Echocardiogram (Movie I in the Data Supplement) revealed mild aortic incompetence, a left ventricular ejection fraction of 60%, aortic root dilatation, and an incidental patent foramen ovale (Movie II in the Data Supplement). Computed tomography (CT) of the thorax demonstrated no tracheal abnormality; however, aortic root dilatation of 4.6 cm was noted ( Figure 3) . A fasting positron emission tomography-CT (PET-CT) showed increased F-18 fluorodeoxyglucose accumulation in the ascending aorta ( Figure 4 ), and a diagnosis of relapsing polychondritis with secondary aortitis with structural aortic dilatation was made.
Therapy with oral prednisone 1 mg/kg and oral methotrexate (25 mg weekly) was commenced immediately. Inflammatory markers failed to settle after 4 months of therapy, and a new femoral bruit was heard, suggesting clinical disease progression that was confirmed on ultrasound scan. The anti-tumor necrosis factor agent infliximab (intravenous infusion 5 mg/ kg 6 weekly) was added to therapy, and oral prednisolone was maintained at 15 to 20 mg/d. Twenty months after diagnosis, the patient developed dyspnoea on exertion without associated chest pain. Investigations for pulmonary edema, methotrexate pneumonitis, pulmonary tuberculosis, and opportunistic infection returned negative, and echocardiographic findings were unchanged. Coronary angiogram identified a critical left main stem ostial stenosis of 90% ( Figure 5 and Movie III in the Data Supplement) that was treated with angioplasty to excellent symptomatic effect. Although the patient reported feeling well, the CRP and ESR remained elevated during the third year of treatment. At this point in time, the ESR was 56 mm/h and the CRP 66 mg/L. The interval fasting PET-CT scan 3 years after diagnosis demonstrated progression of aortitis despite high-dose prednisolone, methotrexate, and infliximab therapy ( Figure 6A and 6B). Both visual interpretation and quantitative measurement of standardized uptake values on serial PET-CT imaging were used at assess change. In the light of PET-CT findings, infliximab was increased to 10 mg/kg (intravenous infusion, 6 weekly), and after 12 months, CRP and ESR were maintained in the normal range (CRP, 8 mg/L; ESR, 10 mm/h) and oral prednisolone was reduced to <10 mg/d. The patient remains asymptomatic.
Relapsing polychondritis is a rare inflammatory condition (reported incidence 3.5 cases/million) affecting cartilaginous tissues such as the ears, nose, and trachea. Diagnostic However, the diagnosis is definitive when ≥1 of the above criteria is met in conjunction with biopsy confirmation. 2 The patient fulfilled this criteria based on biopsy highlighting
Circ Cardiovasc Imaging
March 2014 auricular chondritis in conjunction with recurrent auricular chondritis and nonerosive inflammatory polyarthritis. Cardiovascular involvement is a rare complication of this rare condition; aortic involvement in the form of aortic aneurysm and aortic insufficiency is encountered in 4% to 6% of patients with relapsing polychondritis 3 and is associated with significant mortality. The finding of aortitis with associated coronary ostial lesion is exceedingly rare: there are only 5 cases reported in the literature. Coronary ostial stenosis results from contiguous aortic inflammation that promotes intimal proliferation and luminal contraction in the ascending aorta around the coronary ostia.
The diagnosis of aortic root dilatation secondary to aortitis in this case was made definitively on PET-CT findings. PET-CT is now considered to be a robust clinical tool in the diagnosis of steroid naïve patients with large vessel vasculitis. 4 It has advantages compared with current imaging modalities such as CT, angiography, and MRI because it identifies early inflammatory changes before the development of structural changes, facilitating the introduction of therapeutic agents with the potential to prevent tissue damage and significant morbidity and mortality.
This case of aortitis with critical coronary artery stenosis demonstrates an extremely rare cardiovascular complication of the rare condition relapsing polychondritis. We highlight the clinical use of PET-CT in diagnosing and monitoring progressive inflammation of the aorta in an asymptomatic patient with persistently raised inflammatory markers (CRP >10 mg/L) for whom there was a strong clinical suspicion of disease activity, despite high levels of immunosuppression including a biological agent. In this case, interval PET-CT was key to therapeutic decision making, and we note that CRP settled on high-dose infliximab plus methotrexate and steroid, providing further evidence for biological therapies as effective treatment options in refractory aortitis. In summary, PET-CT was an important diagnostic and therapeutic monitoring tool that guided therapeutic decision making in an extremely rare clinical context.
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